Login to Your Account

Clinic Roundup

Wednesday, October 2, 2013
• Aerial Biopharma LLC, of Morrisville, N.C., reported results from a 12-week, 93-patient Phase IIb study of ADX-NO5 in with excessive daytime sleepiness associated with narcolepsy, which the company said validates data from a Phase IIa proof-of-concept trial in a larger patient population with a longer duration of treatment.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription